EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

First Evaluation of a Novel Pulsatile LVAD: Feasibility and Haemodynamic Impact in Acute Heart Failure

Sara Knigge, Marcelo B Bastos iD, Bastian Schmack, Liam Schana, Oren Malchin, Ali S Merzah, Aron F Popov, Alexander Weymann, Arjang Ruhparwar, Felix Schumacher, Günes Dogan, Jan D Schmitto

ESC Heart Failure · 2025

DOI: 10.1002/ehf2.15410 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ESC Heart Failure, 2025. Verfasst von Sara Knigge und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac-, Thoracic-, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany. Hauptthemen laut MEDLINE: Heart-Assist Devices, Heart Failure, Hemodynamics, Pulsatile Flow. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: PulseCath BV.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Non-pharmacological therapies for acute decompensated heart failure (HF) and cardiogenic shock have evolved considerably in recent decades. Short-term mechanical circulatory support (MCS) devices can be used as circulatory backup. While nearly all available devices use continuous flow, evidence indicates that pulsatile flow can be more effective. This study presents the first experimental use of a novel counter-pulsatile left ventricular (LV) assist device (LVAD) with a primary focus on assessing its feasibility and effectiveness.

Methods

The pulsatile ventricular assist platform (pVAP) was applied in six porcine models of acute ischaemic HF with the inlet in the left atrium and the outlet in the aorta. HF was induced through stepwise ligation of the left anterior descending artery and its diagonal branches. The pVAP functioned driven by a conventional IABP console while LV pressure–volume (PV) loops and standard haemodynamics with the device OFF and ON were recorded. Absolute values and percent variations were compared using Mann–Whitney's U test and Wilcoxon's sign-rank test.

Results

The device's output flow is frequency dependent, with an output flow of 2.64 ± 0.22 L/min at 80 bpm. Activation reduced the EDV [132 (90–145) vs. 118 (83–130) mL, P < 0.05], EDP 9 (6–10) vs. 6 (5–9) mmHg, P < 0.001], native cardiac output [CON, 3.64 (2.88–6.71) vs. 1.67 (1.24–2.48) L/min, P < 0.001] and myocardial oxygen consumption [pressure–volume area * heart rate (PVA*HR), 4592 (2944–9272) vs. 2901 (1915–4437) mJ, P < 0.001]. Contractility decreased, with right-shifting the end-systolic PV relationship (ESPVR) while ESP and forward cardiac output COF were constant. The mean arterial pressure increased [54 (48–60) vs. 49 (42–55) mmHg, P < 0.001] and mPAP decreased [10 (8–11) to 9 (7–10) mmHg, P < 0.01]. The PV loop shifted left and downward. No changes occurred in the passive-elastic properties of the LV in diastole.

Conclusions

The pVAP reduced the LV mechanical load while increasing systemic pressures and reducing pulmonary pressures. Its functionality as an LVAD is characterised by consistent and predictable performance. Further research is necessary to elucidate the physiological and clinical impact of the device in animals and, subsequently, in humans.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart-Assist DevicesHeart FailureHemodynamicsPulsatile FlowVentricular Function, LeftHeart VentriclesAnimalsSwineFeasibility StudiesDisease Models, AnimalAcute DiseaseProsthesis Design

Stichwörter der Autor:innen

counter‐pulsationheart failureleft ventricular assist devicemechanical circulatory supportunloading

Autor:innen und Institutionen

  • Department of Cardiac-, Thoracic-, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.
  • Erasmus Medical Center, Rotterdam, The Netherlands.
  • PulseCath BV, Breukelen, The Netherlands.

ORCID-Profile: Marcelo B Bastos

Förderung

  • PulseCath BV

Zitieren

APA

Knigge, S., Bastos, M. B., Schmack, B., Schana, L., Malchin, O., Merzah, A. S., Popov, A. F., Weymann, A., Ruhparwar, A., Schumacher, F., Dogan, G., & Schmitto, J. D. (2025). First Evaluation of a Novel Pulsatile LVAD: Feasibility and Haemodynamic Impact in Acute Heart Failure. ESC Heart Failure. https://doi.org/10.1002/ehf2.15410

Vancouver

Knigge S, Bastos MB, Schmack B, Schana L, Malchin O, Merzah AS, et al. First Evaluation of a Novel Pulsatile LVAD: Feasibility and Haemodynamic Impact in Acute Heart Failure. ESC Heart Failure. 2025. doi:10.1002/ehf2.15410

BibTeX
@article{Knigge2025,
  author = {Knigge, Sara and Bastos, Marcelo B and Schmack, Bastian and Schana, Liam and Malchin, Oren and Merzah, Ali S and Popov, Aron F and Weymann, Alexander and Ruhparwar, Arjang and Schumacher, Felix and Dogan, Günes and Schmitto, Jan D},
  title = {First Evaluation of a Novel Pulsatile LVAD: Feasibility and Haemodynamic Impact in Acute Heart Failure},
  journal = {ESC Heart Failure},
  year = {2025},
  doi = {10.1002/ehf2.15410}
}
Kostenlos starten →